|
| Exchange Received Time 28/01/2023 12:02:38 Exchange Disseminated Time 28/01/2023 12:02:40 Time Taken 00:00:02 | Revised outcome of the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Friday, 27th January, 2023 had considered and approved the following item:
1. In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Un-Audited Financial Results of the Company for the quarter ended 31st December, 2022 along with the Limited Review Report as issued by M/s. Savla & Associates, Statutory Auditors of the Company; copies of which are attached hereunder;
The Meeting of the Board Commenced at 2.00 P.M. and concluded at 08:00 P.M.
|
|
|